Invention Grant
US09034822B2 Methods of using antibodies during anticoagulant therapy of dabigatran and/or related compounds
有权
在达比加群和/或相关化合物的抗凝治疗期间使用抗体的方法
- Patent Title: Methods of using antibodies during anticoagulant therapy of dabigatran and/or related compounds
- Patent Title (中): 在达比加群和/或相关化合物的抗凝治疗期间使用抗体的方法
-
Application No.: US13916994Application Date: 2013-06-13
-
Publication No.: US09034822B2Publication Date: 2015-05-19
- Inventor: Joanne Van Ryn , John Edward Park , Norbert Hauel , Ulrich Kunz , Tobias Litzenburger , Keith Canada , Sanjaya Singh , Alisa Waterman
- Applicant: Joanne Van Ryn , John Edward Park , Norbert Hauel , Ulrich Kunz , Tobias Litzenburger , Keith Canada , Sanjaya Singh , Alisa Waterman
- Applicant Address: DE Ingelheim am Rhein
- Assignee: Boehringer Igelheim International GmbH
- Current Assignee: Boehringer Igelheim International GmbH
- Current Assignee Address: DE Ingelheim am Rhein
- Agent Michael P. Morris; Wendy A. Petka
- Priority: EP10151239 20100120
- Main IPC: A61K39/395
- IPC: A61K39/395 ; C07K16/44
Abstract:
The present invention relates to antibody molecules against anticoagulants, in particular dabigatran, and their use as antidotes of such anticoagulants.
Public/Granted literature
- US20130289248A1 ANTICOAGULANT ANTIDOTES Public/Granted day:2013-10-31
Information query
